Thiotepa and Pneumothorax - a phase IV clinical study of FDA data

Summary:

Pneumothorax is reported as a side effect among people who take Thiotepa (thiotepa), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Medulloblastoma.

The phase IV clinical study analyzes which people have Pneumothorax when taking Thiotepa. It is created by eHealthMe based on reports of 8,095 people who have side effects when taking Thiotepa from the FDA, and is updated regularly.

What is Thiotepa?

Thiotepa has active ingredients of thiotepa. eHealthMe is studying from 8,097 Thiotepa users. Check the latest studies of Thiotepa.

What is Pneumothorax?

Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung) is found to be associated with 1,236 drugs and 1,346 conditions by eHealthMe. Check the latest studies of Pneumothorax.

On Aug, 10, 2026

8,095 people reported to have side effects when taking Thiotepa.
Among them, 19 people (0.23%) have Pneumothorax.

Among these 19 people:

How long have people been on Thiotepa when they have Pneumothorax? *

What is the gender of people who have Pneumothorax when taking Thiotepa? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Pneumothorax when taking Thiotepa? *

What are other drugs people take besides Thiotepa? *

What are other side effects people have besides Pneumothorax? *

Mucosal Inflammation (infection of mucous membrane): 9 people, 47.37%
Pericardial Effusion (fluid around the heart): 9 people, 47.37%
Weight Increased: 8 people, 42.11%
Nausea (feeling of having an urge to vomit): 8 people, 42.11%
Sepsis (a severe blood infection that can lead to organ failure and death): 8 people, 42.11%
Atelectasis (partial or complete collapse of the lung): 7 people, 36.84%
Dyspnea (difficult or laboured breathing): 7 people, 36.84%
Diplopia (double vision): 7 people, 36.84%
Hepatomegaly (abnormal enlargement of the liver): 7 people, 36.84%
Kidney Infection (Pyelonephritis): 7 people, 36.84%

What are the existing conditions these people have? *

Medulloblastoma (a fast-growing, high-grade tumour that always begins in the cerebellum): 5 people, 26.32%
Fever: 3 people, 15.79%
Recurrent Cancer (repeated cancer): 1 person, 5.26%
Neuroblastoma (a cancer that forms in your nerve tissue): 1 person, 5.26%
Nausea (feeling of having an urge to vomit): 1 person, 5.26%
Immunodeficiency Disorders: 1 person, 5.26%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 5.26%
Depression: 1 person, 5.26%
Constipation: 1 person, 5.26%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Thiotepa and have Pneumothorax?

- Check whether Pneumothorax is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thiotepa:

Thiotepa (8,097 reports)

Pneumothorax treatments and more:

Pneumothorax (19,143 reports)

Browse all side effects of Thiotepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumothorax:

Pneumothorax (1,236 drugs)

Browse all the conditions that are associated with Pneumothorax:

Pneumothorax (1,346 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thiotepa (the active ingredients of Thiotepa) and Thiotepa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.